日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Effect of the Vascular Endothelial Growth Factor Inhibitor Toceranib on Cardiac Function and Endothelial Dysfunction Biomarkers in Dogs With Cancer.

血管内皮生长因子抑制剂托西拉尼对患癌犬心脏功能和内皮功能障碍生物标志物的影响

Lopez Katherine E, Meola Dawn M, Camarda Nicholas D, Upshaw Jenica N, Jaffe Iris Z, London Cheryl A, Yang Vicky K

Identifying mitigating strategies for endothelial cell dysfunction and hypertension in response to VEGF receptor inhibitors.

确定缓解 VEGF 受体抑制剂引起的内皮细胞功能障碍和高血压的策略

Camarda Nicholas D, Lu Qing, Meola Dawn M, Man Joshua J, Song Zeyuan, Travers Richard J, Lopez Katherine E, Powers Sarah N, Papanastasiou Malvina, DeRuff Katherine C, Mullahoo James, Egri Shawn B, Davison Desiree, Sebastiani Paola, Eblen Scott T, Buchsbaum Rachel, Huggins Gordon S, London Cheryl A, Jaffe Jacob D, Upshaw Jenica N, Yang Vicky K, Jaffe Iris Z

Intravenous administration of allogeneic Wharton jelly-derived mesenchymal stem cells for treatment of dogs with congestive heart failure secondary to myxomatous mitral valve disease

静脉注射异体华通氏胶来源间充质干细胞治疗因粘液瘤样二尖瓣疾病继发的充血性心力衰竭犬

Yang, Vicky K; Meola, Dawn M; Davis, Airiel; Barton, Bruce; Hoffman, Andrew M